Impact of medication therapy management programme on diabetes healthcare outcomes in a community pharmacy setting

Not Applicable

Completed

• Conditions: Medication therapy management for chronic disease patients with uncontrolled diabetes; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN60703981
• Lead Sponsor: Princess Nourah bint Abdulrahman University

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34400865/ protocol (added 08/12/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-06-21
• Study Start: 2022-12-09
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

1. Uncontrolled diabetes (defined as having glycated haemoglobin blood (HbA1c) = 8%)
2. Age 18 years and over
3. Able to provide informed consent
4. Have a continuous active status with the medical center (defined as having a record of at least 1 visit in the 6 months before screening)
5. Speak either Arabic or English

Exclusion Criteria

1. Severe mental illness or dementia or significant cognitive impairment
2. Gestational diabetes
3. Unstable acute complications/illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin A1C (HbA1C) levels measured using a blood test at baseline, 3 and 6 months